IN2012DN03330A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN03330A IN2012DN03330A IN3330DEN2012A IN2012DN03330A IN 2012DN03330 A IN2012DN03330 A IN 2012DN03330A IN 3330DEN2012 A IN3330DEN2012 A IN 3330DEN2012A IN 2012DN03330 A IN2012DN03330 A IN 2012DN03330A
- Authority
- IN
- India
- Prior art keywords
- proteins
- virus
- efficient manner
- endoplasmic reticulum
- highly efficient
- Prior art date
Links
- 101710154606 Hemagglutinin Proteins 0.000 abstract 2
- 101710093908 Outer capsid protein VP4 Proteins 0.000 abstract 2
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 abstract 2
- 101710176177 Protein A56 Proteins 0.000 abstract 2
- 210000002472 endoplasmic reticulum Anatomy 0.000 abstract 2
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 108010078791 Carrier Proteins Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000013595 glycosylation Effects 0.000 abstract 1
- 238000006206 glycosylation reaction Methods 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
- 241000712461 unidentified influenza virus Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20090094627 | 2009-10-06 | ||
| KR1020100096488A KR101262300B1 (ko) | 2009-10-06 | 2010-10-04 | 형질전환 식물 유래의 고병원성 조류독감 바이러스 단백질 백신 및 그 제조방법 |
| PCT/KR2010/006821 WO2011043584A2 (ko) | 2009-10-06 | 2010-10-06 | 형질전환 식물 유래의 고병원성 조류독감 바이러스 단백질 백신 및 그 제조방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN03330A true IN2012DN03330A (de) | 2015-10-23 |
Family
ID=44045255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3330DEN2012 IN2012DN03330A (de) | 2009-10-06 | 2010-10-06 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120219580A1 (de) |
| EP (1) | EP2486791A4 (de) |
| KR (1) | KR101262300B1 (de) |
| CN (1) | CN102770016A (de) |
| IN (1) | IN2012DN03330A (de) |
| WO (1) | WO2011043584A2 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101535704B1 (ko) * | 2012-12-28 | 2015-07-27 | 한국생명공학연구원 | 항원성 단백질 고정화를 통한 돈단독 백신 제조방법 |
| EP2970397A2 (de) | 2013-03-14 | 2016-01-20 | University Of Washington Through Its Center For Commercialization | Polypeptide zur behandlung und/oder begrenzung einer influenza-infektion |
| KR101602562B1 (ko) * | 2014-06-10 | 2016-03-10 | 포항공과대학교 산학협력단 | 인플루엔자 a 바이러스 h5n1의 헤마글루티닌을 발현하는 식물체 및 사포닌을 포함하는 경구용 인플루엔자 a 바이러스 h5n1 백신 조성물 |
| US10344293B2 (en) * | 2016-05-12 | 2019-07-09 | Bio Applications Inc. | Vaccine composition for classical swine fever from plant and manufacturing method thereof |
| KR102731582B1 (ko) | 2016-06-03 | 2024-11-15 | 사노피 파스퇴르 인코포레이티드 | 조작된 인플루엔자 헤마글루티닌 폴리펩티드의 변형 |
| CN107058377A (zh) * | 2017-06-16 | 2017-08-18 | 深圳惠升生物科技有限公司 | 植物作为宿主在表达中东呼吸综合征的疫苗中的应用 |
| KR102128453B1 (ko) * | 2018-03-23 | 2020-07-01 | 주식회사 젠바디 | 황열 바이러스 유래 ns1 단백질, 이에 특이적으로 결합하는 단일클론항체 및 이의 용도 |
| KR102138272B1 (ko) * | 2018-09-19 | 2020-07-28 | 주식회사 바이오앱 | BiP 단편을 포함하는 재조합 벡터 및 상기 벡터를 이용한 재조합 단백질의 제조 방법 |
| GB2578163A (en) * | 2018-10-19 | 2020-04-22 | Univ Pretoria | Plant produced avian influenza antigens and their uses in diagnostic assays and devices |
| KR102317403B1 (ko) * | 2019-01-28 | 2021-10-29 | 주식회사 바이오앱 | 당화된 Ag85A 단백질을 포함하는 결핵 예방용 백신 조성물 및 이의 제조방법 |
| KR102209198B1 (ko) * | 2019-04-02 | 2021-02-02 | 주식회사 바이오앱 | 식물에서의 발현이 최적화된 재조합 이리신 유전자 및 이를 이용한 재조합 이리신 단백질의 생산 방법 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040242518A1 (en) * | 2002-09-28 | 2004-12-02 | Massachusetts Institute Of Technology | Influenza therapeutic |
| KR100769584B1 (ko) | 2004-07-30 | 2007-10-23 | 학교법인 포항공과대학교 | 셀룰로오스의 자가가수분해를 위한 셀룰라아제 발현형질전환 식물체 및 이를 이용한 수용성 당의 생산방법 |
| CU23576A1 (es) * | 2006-02-28 | 2010-09-30 | Ct Ingenieria Genetica Biotech | Antígenos vacunales quiméricos contra el virus de la influenza aviar |
| DK2023952T3 (en) * | 2006-05-18 | 2015-10-19 | Epimmune Inc | Induction of immune responses to influenza virus using polypeptide and nucleic acid compositions |
| CN1884517B (zh) * | 2006-06-08 | 2010-06-30 | 武汉禾元生物科技有限公司 | 利用谷物非储藏蛋白为融合载体在胚乳表达多肽的方法及应用 |
| DE602007005017D1 (de) | 2006-10-20 | 2010-04-08 | 3M Innovative Properties Co | Verfahren für leicht zu reinigende substrate und artikel daraus |
| CN101284130B (zh) * | 2007-04-09 | 2011-12-14 | 生宝生物科技股份有限公司 | 利用逆向基因工程技术开发蛋白质疫苗与禽流感疫苗的方法 |
| KR101161622B1 (ko) * | 2009-08-31 | 2012-07-04 | 헬릭스 주식회사 | 번역 효율 증진용 ｄｎａ 단편 및 이를 포함하는 재조합 벡터 |
-
2010
- 2010-10-04 KR KR1020100096488A patent/KR101262300B1/ko active Active
- 2010-10-06 EP EP10822229.0A patent/EP2486791A4/de not_active Withdrawn
- 2010-10-06 US US13/500,762 patent/US20120219580A1/en not_active Abandoned
- 2010-10-06 WO PCT/KR2010/006821 patent/WO2011043584A2/ko not_active Ceased
- 2010-10-06 CN CN2010800563463A patent/CN102770016A/zh active Pending
- 2010-10-06 IN IN3330DEN2012 patent/IN2012DN03330A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2486791A4 (de) | 2013-06-12 |
| CN102770016A (zh) | 2012-11-07 |
| WO2011043584A3 (ko) | 2011-10-20 |
| WO2011043584A2 (ko) | 2011-04-14 |
| EP2486791A2 (de) | 2012-08-15 |
| KR101262300B1 (ko) | 2013-05-20 |
| KR20110037880A (ko) | 2011-04-13 |
| US20120219580A1 (en) | 2012-08-30 |
| WO2011043584A9 (ko) | 2011-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN03330A (de) | ||
| NZ590351A (en) | HA1 domain totally or partially free of N-linked glycosylation operatively linked to a regulatory region | |
| PH12015502217B1 (en) | Influenza virus-like particle production in plants | |
| AR088858A1 (es) | Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para producirlas | |
| EA201001198A1 (ru) | Рекомбинантные вирусоподобные частицы (вч), схожие с вирусом гриппа, производящиеся в трансгенных растениях, экспрессирующих гемагглютинин | |
| MY182643A (en) | Chimeric influenza virus-like particles comprising hemagglutinin | |
| MA32439B1 (fr) | Particules pseudovirales (vlp) de la grippe recombinées produites dans des plantes transgéniques exprimant l'hémagglutinine | |
| WO2010036970A3 (en) | Influenza vaccines, antigens, compositions, and methods | |
| IN2014CN02114A (de) | ||
| NZ627796A (en) | Influenza virus vaccines and uses thereof | |
| HUE058165T2 (hu) | Növényi eredetû fehérjék elõállításának eljárása | |
| MX2011007961A (es) | Determinacion de sexo y metodos de especificacion del mismo. | |
| CL2017001665A1 (es) | Inductor haploide | |
| NZ622731A (en) | Increasing virus-like particle yield in plants | |
| WO2013043067A3 (en) | Dna vaccine, method of inducing the immune response, method of immunisation, antibodies specifically recognising the h5 haemagglutinin of an influenza virus and use of the dna vaccine | |
| MX368142B (es) | Metodo de clonacion, expresion y purificacion novedoso para la preparacion de ranibizumab. | |
| CL2015002175A1 (es) | Vacuna contra el paramixovirus aviar recombinante y su método de preparación y uso | |
| NZ596366A (en) | Enhanced immune response in avian species | |
| EA201300525A1 (ru) | Новые вакцины против пандемичного вируса гриппа a/h1n1 | |
| AR077181A1 (es) | Metodo para proveer plantas recalcitrantes transgenicas maduras por induccion de bbm durante regeneracion | |
| PH12014500369A1 (en) | Influenza h5 vaccines | |
| PH12014500550A1 (en) | Plants having enhanced yield-related traits and a method for making the same | |
| MX2013012986A (es) | Plantas que tienen uno o mas rasgos mejorados relacionados con el rendimento y un metodo para producirlas. | |
| ZA201106852B (en) | A method to prepare inactivated vaccine for h9n2 sub-type avian influenza and product | |
| WO2012061239A3 (en) | Novel vaccines against pandemic influenza virus a/h1n1 |